Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
INTRODUCTION The DNA of protein-coding genes is transcribed into mRNA, which is
translated into proteins. The “coding genome” describes the DNA that contains the …
translated into proteins. The “coding genome” describes the DNA that contains the …
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder.
JY An, K Lin, L Zhu, DM Werling, S Dong… - Science (New York …, 2018 - europepmc.org
Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the
contribution of de novo noncoding mutations to complex disorders. Using WGS, we assess …
contribution of de novo noncoding mutations to complex disorders. Using WGS, we assess …
[HTML][HTML] Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
JY An, K Lin, L Zhu, DM Werling, S Dong… - Science (New York …, 2018 - ncbi.nlm.nih.gov
Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the
contribution of de novo noncoding mutations to complex disorders. Using WGS, we assess …
contribution of de novo noncoding mutations to complex disorders. Using WGS, we assess …
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
JY An, K Lin, L Zhu, DM Werling, S Dong, H Brand… - Science, 2018 - escholarship.org
Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the
contribution of de novo noncoding mutations to complex disorders. Using WGS, we …
contribution of de novo noncoding mutations to complex disorders. Using WGS, we …
[引用][C] Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
JY An, K Lin, L Zhu, DM Werling, S Dong, H Brand… - Science, 2018 - ui.adsabs.harvard.edu
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder -
NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS Genome-wide …
NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS Genome-wide …
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
JY An, K Lin, L Zhu, DM Werling… - … (New York, NY), 2018 - pubmed.ncbi.nlm.nih.gov
Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the
contribution of de novo noncoding mutations to complex disorders. Using WGS, we …
contribution of de novo noncoding mutations to complex disorders. Using WGS, we …
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
안준용 - SCIENCE, 2018 - scholar.korea.ac.kr
Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the
contribution of de novo noncoding mutations to complex disorders. Using WGS, we …
contribution of de novo noncoding mutations to complex disorders. Using WGS, we …
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
JY An, K Lin, L Zhu, DM Werling, S Dong, H Brand… - Science, 2018 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> INTRODUCTION</jats: title>< jats: p> The DNA of protein-coding
genes is transcribed into mRNA, which is translated into proteins. The “coding genome” …
genes is transcribed into mRNA, which is translated into proteins. The “coding genome” …
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder
JY An, K Lin, L Zhu, DM Werling, S Dong, H Brand… - Science, 2018 - pure.korea.ac.kr
Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the
contribution of de novo noncoding mutations to complex disorders. Using WGS, we …
contribution of de novo noncoding mutations to complex disorders. Using WGS, we …
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder.
JY An, K Lin, L Zhu, DM Werling, S Dong… - Science (New York …, 2018 - europepmc.org
Whole-genome sequencing (WGS) has facilitated the first genome-wide evaluations of the
contribution of de novo noncoding mutations to complex disorders. Using WGS, we assess …
contribution of de novo noncoding mutations to complex disorders. Using WGS, we assess …